#247 ‒ Preventing cardiovascular disease: the latest in diagnostic imaging, blood pressure, metabolic health, and more | Ethan Weiss, M.D.
“If everybody got truly optimal medical therapy, if we didn’t have barriers to using all these tools in everybody, I think this disease would largely be controlled.” —Ethan Weiss
#246 – AMA #45: Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent
“The thing that concerns me the most with these drugs. . .is this drive towards sarcopenia.” —Peter Attia
#245 ‒ Overcoming trauma, finding inner peace, and living a meaningful and fulfilling life | Lewis Howes
“I think inner peace is the greatest currency.” —Lewis Howes
#244 ‒ The history of the cell, cell therapy, gene therapy, and more | Siddhartha Mukherjee
“I liken the human genome to a score of music, but a score is lifeless. There’s no music in a score, it’s just a code. You need a musician to bring it to life, and the cell is that musician.” —Sid Mukherjee
#243 ‒ The fentanyl crisis and why everyone should be paying attention | Anthony Hipolito
“Six out of every ten illicit counterfeit pills have enough fentanyl to kill somebody. So if we can take ten pills off the street, we’re potentially saving six lives.” —Anthony Hipolito
#242 – AMA #44: Peter’s historical changes in body composition with his evolving dietary, fasting, and training protocols
“Trends matter. You’re treating what you see, but you’re mindful of the trends.” —Peter Attia
#241 ‒ Living intentionally, valuing time, prioritizing relationships, and more keys to a rich life | Ric Elias (Part 2)
“The day you stop growing is the day that you age.” —Ric Elias
#240 ‒ The confusion around HDL and its link to cardiovascular disease | Dan Rader, M.D.
“HDL cholesterol itself is not directly and causally protective against atherosclerotic cardiovascular disease.” —Dan Rader
#239 ‒ The science of strength, muscle, and training for longevity | Andy Galpin, Ph.D. (PART I)
“The atrophy of fast-twitch fibers is the almost exclusively the problem with aging and muscle.” ‒Andy Galpin
#238 – AMA #43: Understanding apoB, LDL-C, Lp(a), and insulin as risk factors for cardiovascular disease
“ApoB is a necessary, though not sufficient, factor in the development of ASCVD which means the more you lower it, the more you lower risk. Full stop.” —Peter Attia